- Media Release /Scemblix® (asciminib) continues to show superior efficacy with more-than-two-fold improvement in major molecular response rate vs. Bosulif®* (bosutinib) at 96 weeks (37.6% vs. 15.8%), building on 24-…
- Story /
Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub
- Story /
- Featured News /
Latest oncology resources and news surrounding Novartis data featured at European Society for Medical Oncology (ESMO)
- Media Release /In final ELIANA analysis, 55% of patients with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL) who were treated with CAR-T cell therapy Kymriah were still alive after more than…
- Story /
Researchers race to put hydroxychloroquine to the test in a large study.
- Story /
Explaining Chagas disease through the stories of patients in Bolivia.
- Story /
Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.
- Story /
Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.
- Story /
Working with a nonprofit, Novartis is helping train healthcare workers to diagnose and treat chronic ailments such as diabetes.
Pagination
- ‹ Previous page
- 1
- …
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- …
- 264
- › Next page